stanozolol has been researched along with Angioedemas, Hereditary in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Anjani, G; Chopra, S; Jaiswal, M; Jindal, AK; Kaur, A; Longhurst, H; Mahajan, S; Rawat, A; Saini, U; Singh, A; Singh, S | 1 |
Riedl, MA | 1 |
Bork, K | 1 |
Banerji, A; Sheffer, AL; Sloane, DE | 1 |
Cardona, V; Guilarte, M; Labrador-Horrillo, M; López, A; Luengo, O; Muñoz, E; Nogueiras, C | 1 |
3 review(s) available for stanozolol and Angioedemas, Hereditary
Article | Year |
---|---|
Critical appraisal of androgen use in hereditary angioedema: a systematic review.
Topics: Androgens; Angioedemas, Hereditary; Animals; Danazol; Drug Dosage Calculations; Female; Humans; Lipid Metabolism; Menstruation Disturbances; Obesity; Risk Assessment; Stanozolol; Time Factors; Virilism | 2015 |
Current management options for hereditary angioedema.
Topics: Angioedemas, Hereditary; Bradykinin; Complement C1 Inhibitor Protein; Danazol; Disease Management; Humans; Oxandrolone; Peptides; Plasma; Recombinant Proteins; Stanozolol | 2012 |
Hereditary angioedema: a current state-of-the-art review, V: attenuated androgens for the treatment of hereditary angioedema.
Topics: Androgens; Angioedemas, Hereditary; Child; Clinical Trials as Topic; Danazol; Estrogen Antagonists; Female; Humans; Male; Oxymetholone; Stanozolol | 2008 |
2 other study(ies) available for stanozolol and Angioedemas, Hereditary
Article | Year |
---|---|
Successful perioperative management of three patients with hereditary angioedema without C1 esterase inhibitor therapy: A developing country perspective.
Topics: Adult; Angioedemas, Hereditary; Cesarean Section; Complement C1 Inhibitor Protein; Dental Care; Disease Management; Female; Humans; Male; Perioperative Care; Pregnancy; Stanozolol | 2020 |
Acquired angioedema associated with hereditary angioedema due to C1 inhibitor deficiency.
Topics: Angioedema; Angioedemas, Hereditary; Antineoplastic Combined Chemotherapy Protocols; Complement Activation; Complement C1; Complement C1 Inactivator Proteins; Complement C1 Inhibitor Protein; Female; Humans; Lymphocyte Count; Lymphoma, Follicular; Middle Aged; Pedigree; Stanozolol | 2008 |